Literature DB >> 3552327

Obesity as a risk factor for endometrial cancer.

M Gangemi, G Meneghetti, O Predebon, R Scappatura, A Rocco.   

Abstract

The epidemiology and risk factors for endometrial cancer are reviewed, with current data. Obesity seems to be the main risk factor for this neoplasia, both because it is very common in the female population, and because the other risk factor (i.e. estrogen replacement therapy) has almost disappeared with the addition of progesterone therapy. The pathogenesis of obesity as risk factor, although it is not completely clear and unique, is examined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552327

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  3 in total

1.  Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Authors:  Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard C Winneker; Cheryl L Walker; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

2.  An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.

Authors:  Faina Linkov; Lora E Burke; Marina Komaroff; Robert P Edwards; Anna Lokshin; Mindi A Styn; Eugene Tseytlin; Kyle E Freese; Dana H Bovbjerg
Journal:  Gynecol Oncol       Date:  2014-01-22       Impact factor: 5.482

3.  Polymorphisms in inflammation pathway genes and endometrial cancer risk.

Authors:  Ryan J Delahanty; Yong-Bing Xiang; Amanda Spurdle; Alicia Beeghly-Fadiel; Jirong Long; Deborah Thompson; Ian Tomlinson; Herbert Yu; Diether Lambrechts; Thilo Dörk; Marc T Goodman; Ying Zheng; Helga B Salvesen; Ping-Ping Bao; Frederic Amant; Matthias W Beckmann; Lieve Coenegrachts; An Coosemans; Natalia Dubrowinskaja; Alison Dunning; Ingo B Runnebaum; Douglas Easton; Arif B Ekici; Peter A Fasching; Mari K Halle; Alexander Hein; Kimberly Howarth; Maggie Gorman; Dylyara Kaydarova; Camilla Krakstad; Felicity Lose; Lingeng Lu; Galina Lurie; Tracy O'Mara; Rayna K Matsuno; Paul Pharoah; Harvey Risch; Madeleine Corssen; Jone Trovik; Nurzhan Turmanov; Wanqing Wen; Wei Lu; Qiuyin Cai; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-05       Impact factor: 4.254

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.